| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.912 | 0.003 | 0.912 | Aldehyde oxidase inhibitor | 0.243 0.085 CID_154699629 | ||
| 0.808 | 0.01 | 0.808 | Caspase 9 stimulant | 0.775 0.014 CID_154699629 | ||
| 0.745 | 0.009 | 0.745 | 15-Lipoxygenase inhibitor | |||
| 0.738 | 0.027 | 0.905 | Alpha-glucosidase inhibitor | 0.905 0.007 CID_154699629 | CID_154699629 | |
| 0.707 | 0.005 | 0.837 | Histamine release inhibitor | 0.837 0.003 CID_154699629 | CID_154699629 | |
| 0.675 | 0.005 | 0.675 | Superoxide dismutase inhibitor | 0.172 0.152 CID_154699629 | ||
| 0.672 | 0.003 | 0.735 | Carbonic anhydrase XIII inhibitor | 0.735 0.002 CID_154699629 | CID_154699629 | |
| 0.688 | 0.022 | 0.897 | Transcription factor NF kappa B inhibitor | 0.897 0.006 CID_154699629 | CID_154699629 | |
| 0.646 | 0.002 | 0.646 | Carbonic anhydrase XV inhibitor | 0.158 0.028 CID_154699629 | ||
| 0.646 | 0.009 | 0.736 | Spasmolytic | 0.736 0.005 CID_154699629 | CID_154699629 | |
| 0.643 | 0.007 | 0.713 | Free radical scavenger | 0.713 0.005 CID_154699629 | CID_154699629 | |
| 0.642 | 0.009 | 0.76 | Antioxidant | 0.76 0.005 CID_154699629 | CID_154699629 | |
| 0.635 | 0.002 | 0.635 | Carbonic anhydrase III inhibitor | 0.36 0.004 CID_154699629 | ||
| 0.63 | 0.008 | 0.718 | 5 Hydroxytryptamine release inhibitor | 0.718 0.004 CID_154699629 | CID_154699629 | |
| 0.63 | 0.008 | 0.63 | Lipoxygenase inhibitor | |||
| 0.656 | 0.038 | 0.716 | Apoptosis agonist | 0.716 0.028 CID_154699629 | CID_154699629 | |
| 0.613 | 0.003 | 0.613 | 5 Hydroxytryptamine uptake stimulant | 0.245 0.086 CID_154699629 | ||
| 0.61 | 0.007 | 0.61 | Amyloid beta aggregation inhibitor | 0.398 0.025 CID_154699629 | ||
| 0.609 | 0.01 | 0.609 | Caspase 3 stimulant | 0.51 0.019 CID_154699629 | ||
| 0.601 | 0.008 | 0.825 | Vasodilator, coronary | 0.825 0.003 CID_154699629 | CID_154699629 | |
| 0.587 | 0.004 | 0.807 | Amylase inhibitor | 0.807 0.002 CID_154699629 | CID_154699629 | |
| 0.567 | 0.003 | 0.567 | Carbonic anhydrase VI inhibitor | 0.289 0.007 CID_154699629 | ||
| 0.576 | 0.015 | 0.576 | 12-Lipoxygenase inhibitor | |||
| 0.562 | 0.005 | 0.562 | MAO inhibitor | |||
| 0.574 | 0.017 | 0.574 | Aryl hydrocarbon receptor agonist | 0.172 0.119 CID_154699629 | ||
| 0.55 | 0.02 | 0.55 | 5 Hydroxytryptamine release stimulant | 0.495 0.028 CID_154699629 | ||
| 0.544 | 0.016 | 0.544 | GABA C receptor rho-3 antagonist | |||
| 0.557 | 0.031 | 0.557 | Prostaglandin dehydrogenase inhibitor | |||
| 0.499 | 0.01 | 0.499 | Peroxidase inhibitor | |||
| 0.484 | 0.005 | 0.484 | MAO B inhibitor | |||
| 0.481 | 0.005 | 0.481 | MAO A inhibitor | |||
| 0.484 | 0.008 | 0.734 | Monophenol monooxygenase inhibitor | 0.734 0.004 CID_154699629 | CID_154699629 | |
| 0.478 | 0.014 | 0.527 | Vasodilator | 0.527 0.01 CID_154699629 | CID_154699629 | |
| 0.476 | 0.018 | 0.718 | Hypoglycemic | 0.718 0.005 CID_154699629 | CID_154699629 | |
| 0.453 | 0.005 | 0.453 | Aldehyde dehydrogenase inhibitor | 0.45 0.005 CID_154699629 | ||
| 0.458 | 0.019 | 0.458 | Hypoxia-inducible factor 1 alpha inhibitor | 0.432 0.023 CID_154699629 | ||
| 0.434 | 0.01 | 0.56 | Melanin inhibitor | 0.56 0.005 CID_154699629 | CID_154699629 | |
| 0.439 | 0.021 | 0.439 | DNA damaging | 0.43 0.022 CID_154699629 | ||
| 0.419 | 0.006 | 0.419 | Acetylcholinesterase inhibitor | 0.157 0.051 CID_154699629 | ||
| 0.498 | 0.087 | 0.498 | DNA polymerase beta inhibitor | |||
| 0.437 | 0.03 | 0.586 | Apoptosis antagonist | 0.586 0.011 CID_154699629 | CID_154699629 | |
| 0.411 | 0.004 | 0.576 | Xanthine oxidase inhibitor | 0.576 0.003 CID_154699629 | CID_154699629 | |
| 0.398 | 0.003 | 0.398 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.099 0.038 CID_154699629 | ||
| 0.485 | 0.094 | 0.79 | Antiinflammatory | 0.79 0.017 CID_154699629 | CID_154699629 | |
| 0.417 | 0.026 | 0.485 | Antiamyloidogenic | 0.485 0.017 CID_154699629 | CID_154699629 | |
| 0.477 | 0.089 | 0.477 | DNA directed DNA polymerase inhibitor | |||
| 0.411 | 0.025 | 0.657 | Tumour necrosis factor alpha release inhibitor | 0.657 0.005 CID_154699629 | CID_154699629 | |
| 0.39 | 0.009 | 0.518 | Protein kinase stimulant | 0.518 0.004 CID_154699629 | CID_154699629 | |
| 0.383 | 0.004 | 0.383 | Nitric-oxide synthase stimulant | 0.375 0.004 CID_154699629 | ||
| 0.383 | 0.005 | 0.383 | Cystathionine beta-synthase inhibitor | 0.272 0.012 CID_154699629 | ||
| 0.401 | 0.025 | 0.554 | Nitric oxide antagonist | 0.554 0.012 CID_154699629 | CID_154699629 | |
| 0.384 | 0.02 | 0.384 | RNA-directed DNA polymerase inhibitor | 0.281 0.036 CID_154699629 | ||
| 0.375 | 0.011 | 0.539 | DNA methyltransferase I inhibitor | 0.539 0.004 CID_154699629 | CID_154699629 | |
| 0.364 | 0.011 | 0.364 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.295 0.025 CID_154699629 | ||
| 0.356 | 0.004 | 0.356 | Macrophage migration inhibitory factor inhibitor | |||
| 0.4 | 0.049 | 0.609 | Cholesterol antagonist | 0.609 0.018 CID_154699629 | CID_154699629 | |
| 0.363 | 0.012 | 0.363 | Cholinergic | |||
| 0.361 | 0.017 | 0.585 | Hepatoprotectant | 0.585 0.005 CID_154699629 | CID_154699629 | |
| 0.348 | 0.005 | 0.741 | Beta glucuronidase inhibitor | 0.741 0.002 CID_154699629 | CID_154699629 | |
| 0.405 | 0.075 | 0.687 | Antibacterial | 0.687 0.01 CID_154699629 | CID_154699629 | |
| 0.35 | 0.021 | 0.35 | Dual specificity phosphatase 3 inhibitor | |||
| 0.349 | 0.02 | 0.487 | Platelet adhesion inhibitor | 0.487 0.005 CID_154699629 | CID_154699629 | |
| 0.349 | 0.024 | 0.37 | Anesthetic general | 0.37 0.021 CID_154699629 | CID_154699629 | |
| 0.342 | 0.018 | 0.342 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.342 | 0.018 | 0.522 | DNA methylase inhibitor | 0.522 0.005 CID_154699629 | CID_154699629 | |
| 0.327 | 0.007 | 0.327 | Succinate dehydrogenase inhibitor | |||
| 0.32 | 0.004 | 0.453 | Photosensitizer | 0.453 0.003 CID_154699629 | CID_154699629 | |
| 0.382 | 0.071 | 0.537 | Immunosuppressant | 0.537 0.023 CID_154699629 | CID_154699629 | |
| 0.322 | 0.013 | 0.332 | Neurotrophic factor enhancer | 0.332 0.011 CID_154699629 | CID_154699629 | |
| 0.336 | 0.029 | 0.536 | Cyclic AMP phosphodiesterase inhibitor | 0.536 0.005 CID_154699629 | CID_154699629 | |
| 0.303 | 0.004 | 0.397 | Carbonic anhydrase XIV inhibitor | 0.397 0.003 CID_154699629 | CID_154699629 | |
| 0.307 | 0.011 | 0.307 | Alkaline phosphatase inhibitor | 0.273 0.016 CID_154699629 | ||
| 0.364 | 0.069 | 0.364 | Thyroid hormone antagonist | |||
| 0.334 | 0.039 | 0.334 | Pyruvate kinase inhibitor | |||
| 0.311 | 0.017 | 0.369 | Lipid peroxidase inhibitor | 0.369 0.011 CID_154699629 | CID_154699629 | |
| 0.297 | 0.005 | 0.297 | GABA C receptor rho-2 antagonist | |||
| 0.3 | 0.01 | 0.3 | 5-Lipoxygenase inhibitor | |||
| 0.314 | 0.026 | 0.314 | Dual specificity phosphatase inhibitor | |||
| 0.299 | 0.011 | 0.299 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.313 | 0.027 | 0.313 | P-glycoprotein inhibitor | 0.271 0.035 CID_154699629 | ||
| 0.296 | 0.012 | 0.296 | Cholesterol synthesis inhibitor | 0.181 0.032 CID_154699629 | ||
| 0.28 | 0.004 | 0.28 | Creatine kinase inhibitor | |||
| 0.301 | 0.028 | 0.584 | Non-steroidal antiinflammatory agent | 0.584 0.005 CID_154699629 | CID_154699629 | |
| 0.341 | 0.072 | 0.341 | Thyroid hormone beta antagonist | |||
| 0.277 | 0.012 | 0.277 | Butyrylcholinesterase inhibitor | |||
| 0.271 | 0.008 | 0.271 | Histidine decarboxylase inhibitor | |||
| 0.265 | 0.004 | 0.265 | Carbonic anhydrase VB inhibitor | |||
| 0.293 | 0.035 | 0.293 | ErbB-1 antagonist | |||
| 0.268 | 0.011 | 0.268 | Interleukin 4 antagonist | 0.19 0.025 CID_154699629 | ||
| 0.276 | 0.021 | 0.344 | Topoisomerase II inhibitor | 0.344 0.014 CID_154699629 | CID_154699629 | |
| 0.323 | 0.07 | 0.323 | Calcium channel activator | |||
| 0.26 | 0.015 | 0.26 | Chelator | 0.101 0.077 CID_154699629 | ||
| 0.319 | 0.077 | 0.723 | Antithrombotic | 0.723 0.007 CID_154699629 | CID_154699629 | |
| 0.255 | 0.013 | 0.384 | ATPase inhibitor | 0.384 0.004 CID_154699629 | CID_154699629 | |
| 0.245 | 0.005 | 0.245 | Carbonic anhydrase V inhibitor | |||
| 0.26 | 0.021 | 0.26 | Phospholipase A2 inhibitor | 0.201 0.042 CID_154699629 | ||
| 0.264 | 0.027 | 0.264 | Insulin sensitizer | 0.218 0.057 CID_154699629 | ||
| 0.259 | 0.024 | 0.259 | Tubulin antagonist | |||
| 0.305 | 0.074 | 0.305 | Sodium/bile acid cotransporter inhibitor | 0.202 0.185 CID_154699629 | ||
| 0.231 | 0.004 | 0.231 | Carbonic anhydrase VII inhibitor | 0.108 0.009 CID_154699629 | ||
| 0.274 | 0.051 | 0.274 | Antimitotic | |||
| 0.229 | 0.009 | 0.229 | Alcohol dehydrogenase inhibitor | 0.174 0.015 CID_154699629 | ||
| 0.232 | 0.017 | 0.232 | Mannose-6-phosphate isomerase inhibitor | 0.21 0.025 CID_154699629 | ||
| 0.283 | 0.07 | 0.283 | Insulysin inhibitor | |||
| 0.279 | 0.068 | 0.279 | Transcription factor STAT inhibitor | |||
| 0.221 | 0.012 | 0.504 | Mediator release inhibitor | 0.504 0.004 CID_154699629 | CID_154699629 | |
| 0.239 | 0.034 | 0.239 | Tumour necrosis factor antagonist | |||
| 0.272 | 0.068 | 0.272 | Transcription factor STAT3 inhibitor | |||
| 0.237 | 0.034 | 0.237 | Protein-tyrosine phosphatase inhibitor | 0.181 0.055 CID_154699629 | ||
| 0.235 | 0.033 | 0.447 | Diuretic | 0.447 0.01 CID_154699629 | CID_154699629 | |
| 0.227 | 0.026 | 0.227 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.238 | 0.037 | 0.238 | Amyloid beta precursor protein antagonist | |||
| 0.258 | 0.059 | 0.258 | Interleukin antagonist | |||
| 0.204 | 0.008 | 0.204 | Keratolytic | |||
| 0.225 | 0.029 | 0.257 | Interleukin 6 antagonist | 0.257 0.022 CID_154699629 | CID_154699629 | |
| 0.223 | 0.028 | 0.365 | Alpha-N-acetylglucosaminidase inhibitor | 0.365 0.011 CID_154699629 | CID_154699629 | |
| 0.212 | 0.022 | 0.212 | Arachidonic acid antagonist | 0.13 0.113 CID_154699629 | ||
| 0.193 | 0.005 | 0.193 | Carbonic anhydrase VA inhibitor | |||
| 0.207 | 0.02 | 0.207 | Toll-Like receptor 2 antagonist | |||
| 0.199 | 0.015 | 0.257 | Topoisomerase II alpha inhibitor | 0.257 0.01 CID_154699629 | CID_154699629 | |
| 0.206 | 0.025 | 0.291 | Topoisomerase I inhibitor | 0.291 0.012 CID_154699629 | CID_154699629 | |
| 0.194 | 0.014 | 0.194 | Estrogen antagonist | 0.116 0.063 CID_154699629 | ||
| 0.211 | 0.031 | 0.211 | NADPH oxidase inhibitor | 0.164 0.047 CID_154699629 | ||
| 0.204 | 0.027 | 0.204 | DNA polymerase I inhibitor | 0.184 0.033 CID_154699629 | ||
| 0.203 | 0.031 | 0.203 | Interleukin 1 antagonist | |||
| 0.19 | 0.019 | 0.19 | Adenylate cyclase stimulant | 0.123 0.118 CID_154699629 | ||
| 0.179 | 0.012 | 0.179 | Heat shock protein 70 antagonist | 0.171 0.017 CID_154699629 | ||
| 0.171 | 0.005 | 0.171 | Xanthine dehydrogenase inhibitor | 0.065 0.035 CID_154699629 | ||
| 0.173 | 0.01 | 0.257 | Carbonic anhydrase XII inhibitor | 0.257 0.005 CID_154699629 | CID_154699629 | |
| 0.178 | 0.016 | 0.178 | Androgen antagonist | |||
| 0.17 | 0.013 | 0.17 | Ca2+-transporting ATPase inhibitor | 0.162 0.02 CID_154699629 | ||
| 0.169 | 0.012 | 0.169 | HIV-1 integrase (3'-Processing) inhibitor | 0.067 0.041 CID_154699629 | ||
| 0.175 | 0.019 | 0.175 | GABA C receptor antagonist | |||
| 0.197 | 0.042 | 0.36 | Interferon gamma antagonist | 0.36 0.013 CID_154699629 | CID_154699629 | |
| 0.21 | 0.055 | 0.21 | Histone acetyltransferase inhibitor | |||
| 0.159 | 0.004 | 0.159 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.191 | 0.038 | 0.191 | Bone formation stimulant | 0.145 0.063 CID_154699629 | ||
| 0.167 | 0.015 | 0.167 | GABA C receptor rho-1 antagonist | |||
| 0.184 | 0.034 | 0.184 | Protein-tyrosine phosphatase 1B inhibitor | 0.17 0.038 CID_154699629 | ||
| 0.162 | 0.013 | 0.162 | Estrogen receptor beta antagonist | |||
| 0.177 | 0.029 | 0.377 | Cyclooxygenase 3 inhibitor | 0.377 0.004 CID_154699629 | CID_154699629 | |
| 0.174 | 0.027 | 0.488 | Expectorant | 0.488 0.004 CID_154699629 | CID_154699629 | |
| 0.156 | 0.009 | 0.156 | Ornithine decarboxylase inhibitor | 0.111 0.033 CID_154699629 | ||
| 0.176 | 0.03 | 0.176 | Antibacterial (Helicobacter pylori) | 0.111 0.097 CID_154699629 | ||
| 0.167 | 0.022 | 0.167 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.168 | 0.023 | 0.176 | Mucolytic | 0.176 0.02 CID_154699629 | CID_154699629 | |
| 0.242 | 0.1 | 0.509 | Immunostimulant | 0.509 0.028 CID_154699629 | CID_154699629 | |
| 0.159 | 0.017 | 0.159 | DOPA decarboxylase inhibitor | |||
| 0.162 | 0.02 | 0.162 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.265 | 0.124 | 0.265 | Thioredoxin glutathione reductase inhibitor | |||
| 0.165 | 0.024 | 0.359 | UDP-glucose 4-epimerase inhibitor | 0.359 0.007 CID_154699629 | CID_154699629 | |
| 0.297 | 0.156 | 0.297 | Transcription factor inhibitor | |||
| 0.154 | 0.015 | 0.154 | Interleukin 1 beta converting enzyme inhibitor | 0.084 0.083 CID_154699629 | ||
| 0.168 | 0.03 | 0.198 | Microtubule formation inhibitor | 0.198 0.02 CID_154699629 | CID_154699629 | |
| 0.257 | 0.122 | 0.257 | Vasodilator, peripheral | 0.255 0.123 CID_154699629 | ||
| 0.165 | 0.03 | 0.165 | Interleukin 1b antagonist | 0.133 0.053 CID_154699629 | ||
| 0.171 | 0.036 | 0.322 | Alkylator | 0.322 0.011 CID_154699629 | CID_154699629 | |
| 0.147 | 0.013 | 0.168 | Interleukin 12 antagonist | 0.168 0.009 CID_154699629 | CID_154699629 | |
| 0.209 | 0.075 | 0.209 | Psychostimulant | 0.207 0.076 CID_154699629 | ||
| 0.181 | 0.048 | 0.181 | Heat shock protein 90 antagonist | |||
| 0.155 | 0.023 | 0.159 | Multidrug resistance-associated protein 1 inhibitor | 0.159 0.021 CID_154699629 | CID_154699629 | |
| 0.148 | 0.018 | 0.24 | Phosphofructokinase-1 inhibitor | 0.24 0.008 CID_154699629 | CID_154699629 | |
| 0.139 | 0.013 | 0.175 | Carbonic anhydrase IX inhibitor | 0.175 0.01 CID_154699629 | CID_154699629 | |
| 0.139 | 0.014 | 0.139 | CDC25A inhibitor | |||
| 0.176 | 0.053 | 0.176 | Cyclooxygenase inhibitor | 0.122 0.097 CID_154699629 | ||
| 0.146 | 0.023 | 0.146 | Electron transport complex I inhibitor | 0.099 0.085 CID_154699629 | ||
| 0.14 | 0.018 | 0.14 | Carbonic anhydrase inhibitor | 0.127 0.02 CID_154699629 | ||
| 0.14 | 0.019 | 0.14 | CYP2A6 inhibitor | |||
| 0.135 | 0.015 | 0.217 | Phosphodiesterase 6D inhibitor | 0.217 0.004 CID_154699629 | CID_154699629 | |
| 0.184 | 0.065 | 0.184 | Mcl-1 antagonist | |||
| 0.132 | 0.013 | 0.144 | Aldose reductase inhibitor | 0.144 0.011 CID_154699629 | CID_154699629 | |
| 0.134 | 0.015 | 0.134 | Estrogen receptor alpha antagonist | |||
| 0.133 | 0.014 | 0.133 | HIV-1 integrase (Strand Transfer) inhibitor | 0.058 0.043 CID_154699629 | ||
| 0.133 | 0.015 | 0.133 | Aromatase inhibitor | |||
| 0.132 | 0.015 | 0.132 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.13 | 0.014 | 0.142 | ATPase (Vacuolar H+) inhibitor | 0.142 0.009 CID_154699629 | CID_154699629 | |
| 0.174 | 0.06 | 0.174 | Catenin beta inhibitor | |||
| 0.17 | 0.056 | 0.306 | NOS3 expression enhancer | 0.306 0.017 CID_154699629 | CID_154699629 | |
| 0.148 | 0.033 | 0.253 | DNA repair enzyme inhibitor | 0.253 0.005 CID_154699629 | CID_154699629 | |
| 0.12 | 0.005 | 0.12 | Potassium channel Kv1.3 blocker | |||
| 0.153 | 0.041 | 0.198 | DNA intercalator | 0.198 0.026 CID_154699629 | CID_154699629 | |
| 0.214 | 0.103 | 0.376 | DNA synthesis inhibitor | 0.376 0.025 CID_154699629 | CID_154699629 | |
| 0.216 | 0.106 | 0.306 | Interleukin agonist | 0.306 0.045 CID_154699629 | CID_154699629 | |
| 0.113 | 0.004 | 0.113 | Sirtuin 2 inhibitor | |||
| 0.2 | 0.095 | 0.712 | Angiogenesis stimulant | 0.712 0.004 CID_154699629 | CID_154699629 | |
| 0.157 | 0.053 | 0.157 | Cyclooxygenase 1 inhibitor | |||
| 0.168 | 0.065 | 0.168 | Neurotensin receptor agonist | |||
| 0.134 | 0.033 | 0.134 | Urease inhibitor | |||
| 0.15 | 0.053 | 0.15 | Cyclooxygenase 2 inhibitor | 0.105 0.097 CID_154699629 | ||
| 0.127 | 0.031 | 0.127 | Calcium antagonist | |||
| 0.104 | 0.008 | 0.104 | Exportin-1 inhibitor | |||
| 0.142 | 0.047 | 0.142 | Vanilloid 1 agonist | 0.116 0.098 CID_154699629 | ||
| 0.192 | 0.098 | 0.192 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.107 | 0.013 | 0.107 | Androgen agonist | |||
| 0.112 | 0.018 | 0.112 | Caspase 7 inhibitor | |||
| 0.113 | 0.019 | 0.113 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.168 | 0.075 | 0.168 | Phospholipase C inhibitor | |||
| 0.216 | 0.123 | 0.216 | Streptokinase A inhibitor | |||
| 0.103 | 0.01 | 0.103 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.124 | 0.032 | 0.124 | MAP kinase kinase 1 inhibitor | |||
| 0.095 | 0.004 | 0.095 | Dopamine autoreceptor agonist | |||
| 0.112 | 0.022 | 0.132 | Na+ K+ transporting ATPase inhibitor | 0.132 0.011 CID_154699629 | CID_154699629 | |
| 0.098 | 0.009 | 0.098 | CD45 antagonist | |||
| 0.11 | 0.022 | 0.137 | Histone deacetylase stimulant | 0.137 0.012 CID_154699629 | CID_154699629 | |
| 0.11 | 0.022 | 0.137 | Histone deacetylase SIRT1 stimulant | 0.137 0.012 CID_154699629 | CID_154699629 | |
| 0.1 | 0.013 | 0.1 | Aryl hydrocarbon receptor antagonist | |||
| 0.271 | 0.184 | 0.271 | Calcium channel L-type activator | |||
| 0.123 | 0.037 | 0.123 | Breast cancer-resistant protein inhibitor | |||
| 0.102 | 0.017 | 0.102 | Estrogen agonist | 0.085 0.021 CID_154699629 | ||
| 0.11 | 0.026 | 0.11 | Myeloperoxidase inhibitor | |||
| 0.104 | 0.02 | 0.104 | Estrogen-related receptor beta agonist | |||
| 0.139 | 0.055 | 0.139 | Anesthetic local | |||
| 0.101 | 0.018 | 0.101 | Alcohol oxidase inhibitor | |||
| 0.127 | 0.043 | 0.33 | AMP-activated protein kinase stimulant | 0.33 0.005 CID_154699629 | CID_154699629 | |
| 0.088 | 0.005 | 0.088 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.19 | 0.106 | 0.19 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.105 | 0.022 | 0.105 | HIV-1 integrase inhibitor | |||
| 0.139 | 0.058 | 0.139 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.095 | 0.016 | 0.095 | Alpha tubulin antagonist | |||
| 0.103 | 0.025 | 0.103 | Leukotriene synthesis inhibitor | |||
| 0.118 | 0.041 | 0.118 | Anabolic | |||
| 0.094 | 0.019 | 0.094 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.04 CID_154699629 | ||
| 0.116 | 0.04 | 0.137 | Uric acid excretion stimulant | 0.137 0.028 CID_154699629 | CID_154699629 | |
| 0.266 | 0.195 | 0.744 | Cyclophilin D inhibitor | 0.744 0.01 CID_154699629 | CID_154699629 | |
| 0.1 | 0.029 | 0.1 | D-Ala-D-Ala ligase inhibitor | |||
| 0.138 | 0.068 | 0.138 | Farnesoid X receptor antagonist | |||
| 0.079 | 0.009 | 0.11 | Glucose-6-phosphate isomerase inhibitor | 0.11 0.004 CID_154699629 | CID_154699629 | |
| 0.184 | 0.114 | 0.365 | Platelet antagonist | 0.365 0.035 CID_154699629 | CID_154699629 | |
| 0.143 | 0.073 | 0.143 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.171 | 0.103 | 0.171 | MAP kinase kinase 2 inhibitor | |||
| 0.088 | 0.021 | 0.124 | Neuraminidase (influenza) inhibitor | 0.124 0.011 CID_154699629 | CID_154699629 | |
| 0.138 | 0.072 | 0.138 | Cytokine production inhibitor | |||
| 0.077 | 0.011 | 0.077 | Squalene epoxidase inhibitor | |||
| 0.09 | 0.025 | 0.09 | Beta tubulin antagonist | |||
| 0.099 | 0.037 | 0.099 | Chymotrypsin inhibitor | |||
| 0.106 | 0.044 | 0.106 | Antineoplastic alkaloid | |||
| 0.098 | 0.038 | 0.098 | Phosphodiesterase 4D inhibitor | 0.064 0.061 CID_154699629 | ||
| 0.093 | 0.033 | 0.093 | GABA aminotransferase inhibitor | 0.07 0.061 CID_154699629 | ||
| 0.174 | 0.115 | 0.315 | Hypolipemic | 0.315 0.044 CID_154699629 | CID_154699629 | |
| 0.141 | 0.083 | 0.141 | Cytidine deaminase inhibitor | |||
| 0.14 | 0.085 | 0.275 | Insulin secretagoues | 0.275 0.015 CID_154699629 | CID_154699629 | |
| 0.146 | 0.091 | 0.146 | Heat shock protein 90 alpha antagonist | |||
| 0.065 | 0.01 | 0.065 | Dopamine D5 agonist | |||
| 0.101 | 0.046 | 0.252 | Antineoplastic antibiotic | 0.252 0.014 CID_154699629 | CID_154699629 | |
| 0.172 | 0.117 | 0.172 | Dyrk kinase inhibitor | |||
| 0.11 | 0.055 | 0.168 | Toll-Like receptor 4 antagonist | 0.168 0.013 CID_154699629 | CID_154699629 | |
| 0.18 | 0.128 | 0.381 | Peptidyltransferase inhibitor | 0.381 0.008 CID_154699629 | CID_154699629 | |
| 0.076 | 0.024 | 0.076 | Transcription factor AP-1 inhibitor | 0.07 0.03 CID_154699629 | ||
| 0.058 | 0.007 | 0.058 | Catechol O-methyltransferase inhibitor | |||
| 0.09 | 0.039 | 0.09 | Telomerase inhibitor | |||
| 0.129 | 0.078 | 0.129 | Toll-Like receptor 9 antagonist | |||
| 0.078 | 0.027 | 0.102 | Neuraminidase inhibitor | 0.102 0.015 CID_154699629 | CID_154699629 | |
| 0.094 | 0.044 | 0.094 | Glutathione S-transferase inhibitor | |||
| 0.1 | 0.05 | 0.1 | Bile acid receptor antagonist | |||
| 0.083 | 0.035 | 0.083 | Dopamine agonist | |||
| 0.062 | 0.014 | 0.062 | Progesterone antagonist | |||
| 0.058 | 0.011 | 0.058 | DNA gyrase subunit A inhibitor | 0.042 0.031 CID_154699629 | ||
| 0.055 | 0.009 | 0.055 | Retinoid X receptor antagonist | |||
| 0.095 | 0.049 | 0.161 | NADH dehydrogenase inhibitor | 0.161 0.015 CID_154699629 | CID_154699629 | |
| 0.074 | 0.028 | 0.091 | Nitric oxide donor | 0.091 0.013 CID_154699629 | CID_154699629 | |
| 0.056 | 0.012 | 0.056 | Retinoid X alpha receptor agonist | |||
| 0.06 | 0.017 | 0.06 | Cholesterol esterase inhibitor | |||
| 0.081 | 0.039 | 0.081 | GABA B receptor agonist | |||
| 0.086 | 0.044 | 0.086 | Catalase inhibitor | |||
| 0.074 | 0.032 | 0.074 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.081 | 0.04 | 0.097 | Phosphodiesterase VI inhibitor | 0.097 0.022 CID_154699629 | CID_154699629 | |
| 0.082 | 0.042 | 0.082 | Glutamate decarboxylase inhibitor | |||
| 0.08 | 0.04 | 0.08 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.056 | 0.017 | 0.087 | Cytokine production stimulant | 0.087 0.005 CID_154699629 | CID_154699629 | |
| 0.066 | 0.029 | 0.066 | Fatty acid synthase inhibitor | |||
| 0.074 | 0.037 | 0.074 | Dopamine D1 antagonist | |||
| 0.045 | 0.008 | 0.045 | Estrogen-related receptor beta antagonist | |||
| 0.213 | 0.176 | 0.213 | Calpain 2 inhibitor | |||
| 0.096 | 0.059 | 0.096 | Prolactin inhibitor | |||
| 0.067 | 0.03 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.062 | 0.026 | 0.062 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.092 | 0.056 | 0.17 | Triose-phosphate isomerase inhibitor | 0.17 0.015 CID_154699629 | CID_154699629 | |
| 0.045 | 0.01 | 0.045 | Retinoid X alpha receptor antagonist | |||
| 0.089 | 0.054 | 0.089 | Phosphodiesterase IV inhibitor | |||
| 0.13 | 0.096 | 0.398 | Hemostatic | 0.398 0.008 CID_154699629 | CID_154699629 | |
| 0.058 | 0.025 | 0.058 | Vanilloid 2 antagonist | |||
| 0.092 | 0.059 | 0.123 | Thioredoxin inhibitor | 0.123 0.029 CID_154699629 | CID_154699629 | |
| 0.052 | 0.019 | 0.052 | Estrogen receptor beta agonist | |||
| 0.071 | 0.038 | 0.071 | Glutamate (mGluR6) antagonist | |||
| 0.176 | 0.144 | 0.176 | Cardiotonic | |||
| 0.052 | 0.021 | 0.066 | Neuraminidase (Influenza A) inhibitor | 0.066 0.009 CID_154699629 | CID_154699629 | |
| 0.059 | 0.028 | 0.075 | Leukotriene B4 antagonist | 0.075 0.017 CID_154699629 | CID_154699629 | |
| 0.169 | 0.139 | 0.169 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.048 | 0.018 | 0.048 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.048 | 0.019 | 0.048 | Retinoid X receptor agonist | |||
| 0.106 | 0.077 | 0.106 | TRPA1 agonist | |||
| 0.099 | 0.069 | 0.099 | Adenylate kinase inhibitor | |||
| 0.041 | 0.012 | 0.041 | ATP citrate lysase inhibitor | |||
| 0.066 | 0.038 | 0.066 | Transcription factor RelA inhibitor | |||
| 0.068 | 0.041 | 0.068 | Beta adrenoreceptor antagonist | |||
| 0.083 | 0.055 | 0.083 | Thioredoxin reductase inhibitor | |||
| 0.06 | 0.034 | 0.072 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.072 0.025 CID_154699629 | CID_154699629 | |
| 0.058 | 0.032 | 0.058 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.084 | 0.059 | 0.084 | mTOR complex 2 inhibitor | |||
| 0.053 | 0.029 | 0.053 | Topoisomerase II beta inhibitor | |||
| 0.066 | 0.041 | 0.066 | Beta 3 adrenoreceptor antagonist | |||
| 0.039 | 0.016 | 0.039 | Tubulin agonist | |||
| 0.092 | 0.069 | 0.101 | Sphingomyelinase inhibitor | 0.101 0.058 CID_154699629 | CID_154699629 | |
| 0.093 | 0.07 | 0.093 | Protein kinase (CK2) inhibitor | |||
| 0.048 | 0.026 | 0.048 | Carbonic anhydrase IV inhibitor | |||
| 0.102 | 0.084 | 0.102 | Proteasome inhibitor | |||
| 0.046 | 0.029 | 0.046 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.038 | 0.022 | 0.038 | Nicotinic acid receptor 2 agonist | |||
| 0.082 | 0.066 | 0.165 | Transcription factor NF kappa B stimulant | 0.165 0.013 CID_154699629 | CID_154699629 | |
| 0.048 | 0.033 | 0.048 | Aldosterone antagonist | |||
| 0.056 | 0.042 | 0.056 | Pregnane X receptor antagonist | |||
| 0.069 | 0.056 | 0.069 | Glycine receptor agonist | |||
| 0.062 | 0.048 | 0.062 | CDC25B inhibitor | |||
| 0.062 | 0.049 | 0.062 | Leukotriene antagonist | |||
| 0.052 | 0.04 | 0.052 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.055 | 0.043 | 0.055 | Leukotriene C antagonist | |||
| 0.248 | 0.236 | 0.248 | MAP kinase 1 inhibitor | |||
| 0.05 | 0.039 | 0.05 | Aconitate hydratase inhibitor | |||
| 0.035 | 0.023 | 0.035 | Estrogen receptor alpha agonist | |||
| 0.034 | 0.023 | 0.034 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.06 | 0.05 | 0.06 | Phosphodiesterase 1C inhibitor | |||
| 0.136 | 0.128 | 0.136 | Lipocortins synthesis antagonist | |||
| 0.048 | 0.039 | 0.048 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.034 | 0.027 | 0.034 | Nicotinic acid receptor agonist | |||
| 0.022 | 0.015 | 0.022 | Estrone sulfatase inhibitor | |||
| 0.053 | 0.046 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.022 CID_154699629 | CID_154699629 | |
| 0.035 | 0.029 | 0.035 | 5-Alpha-reductase inhibitor | |||
| 0.066 | 0.06 | 0.066 | Porphobilinogen synthase inhibitor | |||
| 0.103 | 0.098 | 0.103 | M17 leucyl aminopeptidase inhibitor | |||
| 0.056 | 0.052 | 0.056 | Ryanodine receptor antagonist | |||
| 0.024 | 0.021 | 0.024 | Thyroid hormone agonist | |||
| 0.036 | 0.033 | 0.036 | DNA-dependent protein kinase inhibitor | |||
| 0.047 | 0.045 | 0.095 | Glucose-6-phosphate translocase inhibitor | 0.095 0.007 CID_154699629 | CID_154699629 | |
| 0.048 | 0.045 | 0.048 | Carbonic anhydrase I inhibitor | |||
| 0.078 | 0.076 | 0.078 | Vanilloid agonist | |||
| 0.052 | 0.05 | 0.052 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.066 | 0.064 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.102 | 0.1 | 0.102 | Transcription factor STAT6 inhibitor | |||
| 0.053 | 0.051 | 0.053 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.024 | 0.024 | 0.112 | Sodium/glucose cotransporter 2 inhibitor | 0.112 0.002 CID_154699629 | CID_154699629 | |
| 0.03 | 0.032 | 0.055 | Arginase inhibitor | 0.055 0.012 CID_154699629 | CID_154699629 | |
| 0.023 | 0.026 | 0.102 | Sodium/glucose cotransporter inhibitor | 0.102 0.003 CID_154699629 | CID_154699629 | |
| 0.111 | 0.114 | 0.24 | Cell wall synthesis inhibitor | 0.24 0.018 CID_154699629 | CID_154699629 | |
| 0.035 | 0.054 | 0.054 | Microtubule stabilization | 0.054 0.023 CID_154699629 | CID_154699629 | |
| 0.012 | 0.032 | 0.017 | Telomerase stimulant | 0.017 0.013 CID_154699629 | CID_154699629 | |
| 0.049 | 0.076 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 CID_154699629 | CID_154699629 | |
| 0.004 | 0.032 | 0.015 | Antibiotic Macrolide-like | 0.015 0.009 CID_154699629 | CID_154699629 | |
| 0.035 | 0.064 | 0.111 | Protein 50S ribosomal subunit inhibitor | 0.111 0.011 CID_154699629 | CID_154699629 | |
| 0.018 | 0.048 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 CID_154699629 | CID_154699629 | |
| 0.07 | 0.103 | 0.09 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.09 0.065 CID_154699629 | CID_154699629 | |
| 0.012 | 0.052 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_154699629 | CID_154699629 | |
| 0.097 | 0.138 | 0.322 | Thrombolytic | 0.322 0.02 CID_154699629 | CID_154699629 | |
| 0.114 | 0.158 | 0.146 | CC chemokine 6 receptor antagonist | 0.146 0.028 CID_154699629 | CID_154699629 | |
| 0.066 | 0.116 | 0.078 | Interleukin 5 antagonist | 0.078 0.077 CID_154699629 | CID_154699629 | |
| 0.057 | 0.108 | 0.106 | Glycine receptor antagonist | 0.106 0.027 CID_154699629 | CID_154699629 | |
| 0.006 | 0.057 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_154699629 | CID_154699629 | |
| 0.036 | 0.095 | 0.103 | Heparanase inhibitor | 0.103 0.004 CID_154699629 | CID_154699629 | |
| 0.036 | 0.11 | 0.049 | Factor III inhibitor | 0.049 0.036 CID_154699629 | CID_154699629 | |
| 0.051 | 0.125 | 0.076 | Interferon agonist | 0.076 0.059 CID_154699629 | CID_154699629 | |
| 0.031 | 0.106 | 0.072 | Alpha-mannosidase inhibitor | 0.072 0.015 CID_154699629 | CID_154699629 | |
| 0.021 | 0.106 | 0.067 | Mannosidase inhibitor | 0.067 0.013 CID_154699629 | CID_154699629 | |
| 0.013 | 0.106 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.023 CID_154699629 | CID_154699629 | |
| 0.032 | 0.158 | 0.057 | DNA gyrase inhibitor | 0.057 0.053 CID_154699629 | CID_154699629 | |
| 0.006 | 0.134 | 0.028 | Squalene synthetase inhibitor | 0.028 0.025 CID_154699629 | CID_154699629 | |
| 0.019 | 0.156 | 0.073 | Antibiotic Aminoglycoside-like | 0.073 0.005 CID_154699629 | CID_154699629 | |
| 0.01 | 0.155 | 0.046 | Protein 30S ribosomal subunit inhibitor | 0.046 0.009 CID_154699629 | CID_154699629 | |
| 0.016 | 0.164 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_154699629 | CID_154699629 | |
| 0.02 | 0.183 | 0.329 | Selectin antagonist | 0.329 0.004 CID_154699629 | CID_154699629 | |
| 0.072 | 0.248 | 0.16 | Hexokinase inhibitor | 0.16 0.068 CID_154699629 | CID_154699629 | |
| 0.139 | 0.329 | 0.384 | Interleukin 2 agonist | 0.384 0.032 CID_154699629 | CID_154699629 | |
| 0.057 | 0.255 | 0.219 | Cell adhesion inhibitor | 0.219 0.02 CID_154699629 | CID_154699629 | |
| 0.056 | 0.254 | 0.081 | T cell inhibitor | 0.081 0.061 CID_154699629 | CID_154699629 | |
| 0.106 | 0.319 | 0.196 | Angiogenesis inhibitor | 0.196 0.174 CID_154699629 | CID_154699629 | |
| 0.047 | 0.313 | 0.23 | Anticoagulant | 0.23 0.044 CID_154699629 | CID_154699629 | |
| 0.016 | 0.533 | 0.057 | Factor IXa inhibitor | 0.057 0.029 CID_154699629 | CID_154699629 | |
| 0.052 | 0.569 | 0.347 | Immunomodulator | 0.347 0.061 CID_154699629 | CID_154699629 | |
| 0.013 | 0.562 | 0.081 | Cell adhesion molecule inhibitor | 0.081 0.052 CID_154699629 | CID_154699629 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |